VENUSREM
Start SIP
Invest Now
Start SIP in VENUSREM
Performance
- Low
- ₹726
- High
- ₹761
- 52 Week Low
- ₹278
- 52 Week High
- ₹840
- Open Price₹750
- Previous Close₹762
- Volume8,952
- 50 DMA₹731.53
- 100 DMA₹667.37
- 200 DMA₹575.31
Investment Returns
- Over 1 Month -4.11%
- Over 3 Month + 29.03%
- Over 6 Month + 55.75%
- Over 1 Year + 132.25%
Smart Investing Starts Here Start SIP with Venus Remedies for Steady Growth!
Venus Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.9
- PEG Ratio
- 0.1
- Market Cap Cr
- 986
- P/B Ratio
- 1.7
- Average True Range
- 44.01
- EPS
- 57.09
- Dividend Yield
- 0
- MACD Signal
- 3.58
- RSI
- 46.97
- MFI
- 59.31
Venus Remedies Financials
Venus Remedies Technicals
EMA & SMA
Current Price
₹737.85
-24
(-3.15%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹754.54
- 50 Day
- ₹731.53
- 100 Day
- ₹667.37
- 200 Day
- ₹575.31
Resistance and Support
741.68
- R3 791.97
- R2 776.48
- R1 757.17
- S1 722.37
- S2 706.88
- S3 687.57
Venus Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-29 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-10 | Quarterly Results | |
| 2025-08-01 | Quarterly Results | |
| 2025-07-08 | Others | Inter-alia, to consider 1. Notice of 36th Annual General Meeting. 2. Boards Report for Financial Year 2024-2025. 3. Other business matters. |
| 2025-05-26 | Audited Results |
Venus Remedies F&O
About Venus Remedies
- NSE Symbol
- VENUSREM
- BSE Symbol
- 526953
- Chairman & Managing Director
- Mr. Pawan Chaudhary
- ISIN
- INE411B01019
Similar Stocks to Venus Remedies
Venus Remedies FAQs
Venus Remedies share price is ₹737 As on 16 February, 2026 | 04:43
The Market Cap of Venus Remedies is ₹986.3 Cr As on 16 February, 2026 | 04:43
The P/E ratio of Venus Remedies is 12.9 As on 16 February, 2026 | 04:43
The PB ratio of Venus Remedies is 1.7 As on 16 February, 2026 | 04:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.